GENPREX INC. news, videos and press releases - Page 3
For more news please use our advanced search feature.
GENPREX INC. - More news...
GENPREX INC. - More news...
- Genprex to Present at the MoneyShow June Virtual Event
- Genprex Announces Receipt of $2.5 Million in Cash from Recent Warrant Exercises
- Genprex Enters Into Exclusive Worldwide Patent and Technology License Agreement for Combination of its TUSC2 Gene Therapy with Immunotherapies
- Genprex Issues April 2020 Shareholder Letter
- Genprex Appoints Shannon Inman as Vice President of Global Clinical Operations
- Genprex Bolsters Board of Directors, Appoints Three Biotechnology and Healthcare Industry Leaders
- Genprex Strengthens Leadership Team with the Appointment of Two Accomplished Life Science Executives
- Lead Researcher Behind Genprex’s Diabetes Gene Therapy Featured in New Video Interview
- Genprex to Present at the 2020 LD Micro Virtual Conference
- Genprex to Present at the 2020 LD Micro Virtual Conference
- Genprex, Inc. Announces Closing of $17,500,000 Common Stock Offering At-The-Market and Without Warrants
- Genprex, Inc. Prices $17,500,000 Common Stock Offering Priced At-The-Market and Without Warrants
- Genprex and University of Pittsburgh Sign Exclusive License Agreement for Potentially Curative Gene Therapy Candidate for Diabetes
- Genprex Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Genprex to Focus Its Clinical Efforts on Oncoprex™ in Combination Therapy with Osimertinib for Non-Small Cell Lung Cancer (NSCLC)
- Genprex to Present at NobleCon16 Investor Conference
- Independent Researchers Find Genprex’s TUSC2 May Be a Novel Target and Biomarker for Thyroid Cancer Therapy
- Genprex, Inc. Announces Closing of $8 Million At-The-Market Common Stock Offering
- Genprex, Inc. Prices $8,000,000 Common Stock Offering Priced At-The-Market
- Genprex Receives U.S. FDA Fast Track Designation for Gene Therapy that Targets Lung Cancer
- Genprex to Present at Biotech Showcase™ 2020 in San Francisco
- Genprex to Present at the MicroCap Rodeo Investor Conference
- Genprex’s Pioneering Use of Non-Viral Delivery for Gene Therapy is Gaining Industry Support
- Genprex (GNPX) Featured in Audio Publication Discussing New Research on Breast Cancer Treatment
- Genprex (GNPX) Featured in Publication on Advances in Potential Breast Cancer Treatments
- Genprex to Present Via Webcast at the Singular Research Midwestern Values Conference on September 19, 2019
- Independent Researchers Find Genprex’s TUSC2 Prevents Tumor Growth in Triple-Negative Breast Cancer
- Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy Treatments
- Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer
- Genprex to Present at the H.C. Wainwright 21st Annual Global Investment Conference
